Advancing transformation into a diversified biomedical innovation company with a clear path to cash flow positive Oramed ...
Advancing transformation into a diversified biomedical innovation company with a clear path to cash flow positive Oramed strategic transaction receives shareholder approval- Lifeward gains new oral ...
Welcome to InPost Fourth Quarter and Full Year 2025 Earnings Call. A usual disclaimer, today's call includes forward-looking statements that are subject to risks, and it is possible that the actual ...
Docusign, Inc. (NASDAQ: DOCU) today announced results for its fourth quarter and fiscal year ended January 31, 2026.
Millions of taxpayers are using a new IRS form to claim deductions for tips, overtime, car loan interest, and seniors. What is Schedule 1-A?
This is HealthEquity, Inc.'s fourth quarter fiscal 2026 earnings conference call. Before I turn the call over to Scott for our prepared remarks, we note that the press release announcing our fourth ...
Detailed price information for Lifemd Inc 8.875% Series A (LFMDP-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results